BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gunduz H, Karabay O, Tamer A, Özaras R, Mert A, Tabak &F. N-acetyl cysteine therapy in acute viral hepatitis. World J Gastroenterol 2003; 9(12): 2698-2700 [PMID: 14669316 DOI: 10.3748/wjg.v9.i12.2698]
URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2698.htm
Number Citing Articles
1
J. Wiegand, H. Wedemeyer, A. Franke, S. Rößler, S. Zeuzem, G. Teuber, M. Wächtler, U. Römmele, B. Ruf, U. Spengler, C. Trautwein, C. T. Bock, G. M. Fiedler, J. Thiery, M. P. Manns, O. Brosteanu, H. L. Tillmann. Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double‐blinded multicentre trialJournal of Viral Hepatitis 2014; 21(10): 744 doi: 10.1111/jvh.12210
2
Ameer Abutaleb, Shyam Kottilil. Hepatitis AGastroenterology Clinics of North America 2020; 49(2): 191 doi: 10.1016/j.gtc.2020.01.002
3
Ji-Hoon Park, Kang-Sik Seo, Surendar Tadi, Bong-Hyun Ahn, Jung-Uee Lee, Jun-Young Heo, Jeongsu Han, Myoung-Sub Song, Soon-Ha Kim, Yong-Hyeon Yim, Hueng-Sik Choi, Minho Shong, GiRyang Kweon. An Indole Derivative Protects Against Acetaminophen-Induced Liver Injury by Directly Binding to N-Acetyl-p-Benzoquinone Imine in MiceAntioxidants & Redox Signaling 2013; 18(14): 1713 doi: 10.1089/ars.2012.4677
4
R. Bruno, G. Carosi, N. Coppola, G. B. Gaeta, M. Puoti, T. Santantonio, G. Taliani, O. Armignacco, E. Sagnelli, M. Andreoni, G. Angarano, G. Di Perri, G. D’Offizi, M. Galli, G. Rizzardini. Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT)Infection 2014; 42(5): 811 doi: 10.1007/s15010-014-0642-0
5
Muthusamy Sureshan, Sathishkumar Brintha, Arunachalam Jothi. Identification of Mulberrofuran as a potent inhibitor of hepatitis A virus 3Cpro and RdRP enzymes through structure-based virtual screening, dynamics simulation, and DFT studiesMolecular Diversity 2023;  doi: 10.1007/s11030-023-10679-7
6
Mihai Popescu, Angelica Bratu, Mihaela Agapie, Tudor Borjog, Mugurel Jafal, Romina-Marina Sima, Carmen Orban. The Use and Potential Benefits of N-Acetylcysteine in Non-Acetaminophen Acute Liver Failure: An Etiology-Based ReviewBiomedicines 2024; 12(3): 676 doi: 10.3390/biomedicines12030676
7
Navroop Nagra, Richard A. Kozarek, Blaire E. Burman. Therapeutic Advances in Viral Hepatitis A–EAdvances in Therapy 2022; 39(4): 1524 doi: 10.1007/s12325-022-02070-z
8
Kenneth E. Sherman, Shyam Kottilil. Schiff's Diseases of the Liver2017; : 563 doi: 10.1002/9781119251316.ch23
9
Samar K. Darweesh, Mona F. Ibrahim, Mahmoud A. El-Tahawy. Effect of N-Acetylcysteine on Mortality and Liver Transplantation Rate in Non-Acetaminophen-Induced Acute Liver Failure: A Multicenter StudyClinical Drug Investigation 2017; 37(5): 473 doi: 10.1007/s40261-017-0505-4
10
Veronika Gagovic, Paul Kwo. Chronic Viral Hepatitis2009; : 289 doi: 10.1007/978-1-59745-565-7_11
11
Filippo Gabrielli, Francesco Alberti, Cristina Russo, Carmela Cursaro, Hajrie Seferi, Marzia Margotti, Pietro Andreone. Treatment Options for Hepatitis A and E: A Non-Systematic ReviewViruses 2023; 15(5): 1080 doi: 10.3390/v15051080
12
Pietro Torre, Andrea Aglitti, Mario Masarone, Marcello Persico. Viral hepatitis: Milestones, unresolved issues, and future goalsWorld Journal of Gastroenterology 2021; 27(28): 4603-4638 doi: 10.3748/wjg.v27.i28.4603
13
Waleed Aljohani, Brian Pak Ho Chan, Mohammad Yaghoobi. Role ofN-Acetylcysteine in the Treatment of Acute Nonacetaminophen, Nonalcoholic and Nonviral Hepatitis: A Meta-analysisJournal of the Canadian Association of Gastroenterology 2021; 4(3): 125 doi: 10.1093/jcag/gwaa017
14
S. Yu. Chikina. Fluimucil and recent clinical practicePULMONOLOGIYA 2005; (4): 97 doi: 10.18093/0869-0189-2005-0-4-97-111
15
Vinod V. S, Vijithkumar K, Riyas C, Malini V. S, Arun S. Menon. A Study on the Role of N-Acetyl Cysteine Therapy in Acute Viral Hepatitis AJournal of Evidence Based Medicine and Healthcare 2020; 7(22): 1068 doi: 10.18410/jebmh/2020/231
16
Kamolwish Laoprasopwattana, Puttichart Khantee, Kantara Saelim, Alan Geater. Mortality Rates of Severe Dengue Viral Infection Before and After Implementation of a Revised Guideline for Severe DenguePediatric Infectious Disease Journal 2022; 41(3): 211 doi: 10.1097/INF.0000000000003411
17
Hans L. Tillmann, Kalliopi Zachou, George N. Dalekos. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?Liver International 2012; 32(4): 544 doi: 10.1111/j.1478-3231.2011.02682.x
18
Yong Sun, Li-Yong Pu, Ling Lu, Xue-Hao Wang, Feng Zhang, Jian-Hua Rao. N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injuryWorld Journal of Gastroenterology 2014; 20(41): 15289-15298 doi: 10.3748/wjg.v20.i41.15289
19
Mariapia Vairetti, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Andrea Ferrigno, Clarissa Berardo. Changes in Glutathione Content in Liver Diseases: An UpdateAntioxidants 2021; 10(3): 364 doi: 10.3390/antiox10030364
20
László Galgóczy, Laura Kovács, Krisztina Krizsán, Tamás Papp, Csaba Vágvölgyi. Inhibitory Effects of Cysteine and Cysteine Derivatives on Germination of Sporangiospores and Hyphal Growth of Different ZygomycetesMycopathologia 2009; 168(3): 125 doi: 10.1007/s11046-009-9204-x
21
Najmolsadat Atefi, Elham Behrangi, Samaneh Mozafarpoor, Farnoosh Seirafianpour, Shadi Peighambari, Azadeh Goodarzi. N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review studyJournal of Research in Medical Sciences 2020; 25(1): 109 doi: 10.4103/jrms.JRMS_777_20
22
Jacky TP Siu, Trina Nguyen, Ricky D Turgeon. N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failureCochrane Database of Systematic Reviews 2020; 2020(12) doi: 10.1002/14651858.CD012123.pub2